Mildronate dihydrate
Product Code:
CDX-M0558
CDX-M0558
Regulatory Status:
RUO
RUO
Shipping:
AMBIENT
AMBIENT
Storage:
Short Term: +4°C, Long Term: -20°C
Short Term: +4°C, Long Term: -20°C
No additional charges, what you see is what you pay! *
| Code | Size | Price |
|---|
| CDX-M0558-M010 | 10 mg | £41.00 |
Quantity:
| CDX-M0558-M025 | 25 mg | £78.00 |
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
- Further Information
- Documents
- References
- Show All
Further Information
Alternate Names/Synonyms:
Meldonium; MET 88; Quaterin; THP
Appearance:
White to off-white powder.
CAS:
86426-17-7
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS07
Handling Advice:
Protect from light and moisture.
Hazards:
H315-H319-H335
InChi:
InChI=1S/C6H14N2O2/c1-8(2,3)7-5-4-6(9)10/h7H,4-5H2,1-3H3
InChiKey:
PVBQYTCFVWZSJK-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 86426-17-7. Formula: C6H14N2O2 . 2H2O. MW: 182.22. Mildronate is a structural analog of gamma-butyrobetaine (gammaBB), an intermediate in the biosynthesis of carnitine and a modulator of energy metabolism. It blocks carnitine synthesis by inhibiting gammaBB hydroxylase (BBOX) and, less potently, carnitine acetyltransferase (CrAT). Through these actions, mildronate reduces the levels of free carnitine and long chain acyl carnitine. This leads to suppressed fatty acid metabolism and mitochondrial uncoupling during oxidative conditions, resulting in cardioprotective, antidiabetic and neuroprotective effects. Mildronate also improves cognition and reduces amyloid-beta pathology in a mouse model of Alzheimer?s disease.
MDL:
MFCD00876389
Molecular Formula:
C6H14N2O2 . 2H2O
Molecular Weight:
182.22
Package Type:
Vial
Precautions:
P261-P305 + P351 + P338
Product Description:
Mildronate is a structural analog of gamma-butyrobetaine (gammaBB), an intermediate in the biosynthesis of carnitine and a modulator of energy metabolism. It blocks carnitine synthesis by inhibiting gammaBB hydroxylase (BBOX) and, less potently, carnitine acetyltransferase (CrAT). Through these actions, mildronate reduces the levels of free carnitine and long chain acyl carnitine. This leads to suppressed fatty acid metabolism and mitochondrial uncoupling during oxidative conditions, resulting in cardioprotective, antidiabetic and neuroprotective effects. Mildronate also improves cognition and reduces amyloid-beta pathology in a mouse model of Alzheimer?s disease.
Purity:
>98% (HPLC)
Signal word:
Warning
SMILES:
[O-]C(CCN[N+](C)(C)C)=O
Solubility Chemicals:
Soluble in water (20mg/ml) or ethanol (20mg/ml).
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
Documents
References
(1) B.Z. Simkhovich, et al.; Biochem. Pharmacol. 37, 195 (1988) | (2) M. Dambrova, et al.; Trends Cardiovasc. Med. 12, 275 (2002) (Review) | (3) E. Liepinsh, et al.; J. Cardiovasc. Pharmacol. 48, 314 (2006) | (4) R. Vilskersts, et al.; Pharmacology 83, 287 (2009) | (5) K. Jaudzems, et al.; J. Enzyme Inhib. Med. Chem. 24, 1269 (2009) | (6) J. Pupure, et al.; Neurosci. Lett. 470, 100 (2010) | (7) V.Z. Klusa, et al.; Int. J. Mol. Sci. 11, 4465 (2010) | (8) I.K. Leung, et al.; Chem. Biol. 17, 1316 (2010) | (9) E. Liepinsh, et al.; Eur. J. Pharmacol. 658, 277 (2011) | (10) K. Tars, et al.; J. Med. Chem. 57, 2213 (2014) | (11) U. Beitnere, et al.; J. Neurosci. Res. 92, 338 (2014) | (12) M. Makrecka, et al.; Eur. J. Pharmacol. 723, 55 (2014)